TARVEDA THERAPEUTICS, INC.

Profile

Company Names

TARVEDA THERAPEUTICS, INC.
BLEND THERAPEUTICS, INC.
BLEND BIOSCIENCES, INC.

Addresses

134 COOLIDGE AVENUE, WATERTOWN, MA 02472

C/O EMERGING ENTERPRISE CENTER, 1000 WINTER STREET, SUITE 4000, WALTHAM, MA 02451

Phone Numbers

617-923-4100
617-832-1205

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$127,435,345.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2021-09-15 
$5,999,999.00 
$5,999,999.00 
$0.00 
Equity 
7
2020-12-15 
$14,999,994.00 
$15,433,472.00 
$433,478.00 
Equity 
6
2019-12-12 
$13,634,188.00 
$13,634,188.00 
$0.00 
Equity 
5
2017-01-31 
$30,000,001.00 
$30,000,001.00 
$0.00 
Equity 
4
2016-01-15 
$38,000,000.00 
$38,000,000.00 
$0.00 
Equity 
3
2014-02-28 
$999,999.00 
$999,999.00 
$0.00 
Equity 
2
2012-12-14 
$21,001,164.00 
$21,001,168.00 
$4.00 
Equity 
1
2011-08-22 
$2,800,000.00 
$2,800,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEILA 
 
ALLAND 
EXECUTIVE OFFICER
SHADI 
 
ARYANPOUR 
EXECUTIVE OFFICER
OMID 
C. 
FAROKHZAD 
DIRECTOR, PROMOTER
ANDREW 
 
FROMKIN 
EXECUTIVE OFFICER, DIRECTOR
ANDREW 
J. 
FROMKIN 
EXECUTIVE OFFICER, DIRECTOR
MARK 
 
IWICKI 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
ROBERT 
S. 
LANGER, JR. 
DIRECTOR
GUIDO 
 
MAGNI 
DIRECTOR
JEFFREY 
 
QUILLEN 
EXECUTIVE OFFICER
RICHARD 
 
WOOSTER 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-28 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MTS SECURITIES, LLC